Affiliation:
1. Regional Children’s Clinical Hospital No. 1
2. North-Western State Medical University named after I.I. Mechnikov
3. Regional Children’s Clinical Hospital No. 1;
Pacific State Medical University
4. Pacific State Medical University
Abstract
The review of studies of international and national researchers on the impact of matrix metalloproteinases (matrix metalloproteinases, ММРs) and their inhibitors (tissue inhibitors of metalloproteinases, TIMPs) on physiological and pathological processes in children with kidney diseases. It is shown that MMPs play a significant role in organogenesis, i.e. nephrogenesis. Thus, MMP-2, MMP-9 and TIMPs play a large role in basal membranes remodeling associated with epithelial structures in a developing kidney. Immunohistochemistry assay showed that MMP-2 was localized in structures of immature nephrons undergoing epithelial differentiation, MMP-9 – only in vascular structures included in immature glomeruli. Decreased activity of MMP and /or increased synthesis of TIMPs in nephrocytes contribute to the reduction of intercellular substance components catabolism and serve as a basis for glomerular fibrosis and renal interstitium. MMPs are the major group of proteases which regulate metabolism in extracellular matrix and serve as the most important parameters in tissue remodeling observed in acute and chronic inflammatory processes in kidneys. The literature review gives an opportunity to assess the importance of drug design preventing and delaying the progression of nephrosclerosis.
Publisher
Pacific State Medical University
Reference24 articles.
1. Rogova LN, Shesternina NV, Zamechnik TV, Fastova IA. Matrix metalloproteinases, their role in physiological and pathological processes (Review). Bulletin of New Medical Technologies. 2011;8(2):86–9 (In Russ).
2. Markelova EV, Zdor VV, Romanchuk AL, Birko ON. Matrix metalloproteinases their relationship with the cytokine system, diagnostic and prognostic potential. Immunopathology, Allergology, Infectology. 2016;2:11–22 (In Russ).
3. Ning Cui, Min Hu, Raouf A. Khalil. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1–73.
4. Sukhanova GA, Terentyeva AA, Kuvshinov NN. The role of matrix metalloproteinases and their tissue inhibitors in the development of complications of kidney diseases in children. Bulletin of Siberian Medicine. 2015;14(3):35–9 (In Russ).
5. Kobusiak-Prokopowicz M, Krzysztofik J, Kaaz K, Jolda-Mydlowska B, Mysiak A. MMP-2 and TIMP-2 in patients with heart failure and chronic kidney disease. Open Medicine. 2018;13(1):237–46.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献